psigryph
Kitchener, CA · 1 known investors
Psigryph develops Nanopect, a patented plant-derived nanodelivery system that transports bioactive molecules (nutrients, cannabinoids, pharmaceuticals) across cell membranes of plants, animals, and humans to increase bioavailability. The technology, derived from Montmorency sour cherries, targets industries including food and beverage, agriculture, pharmaceutical, and cannabis.